269 related articles for article (PubMed ID: 22405189)
1. Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α.
Scuderi C; Valenza M; Stecca C; Esposito G; Carratù MR; Steardo L
J Neuroinflammation; 2012 Mar; 9():49. PubMed ID: 22405189
[TBL] [Abstract][Full Text] [Related]
2. Neuroglial roots of neurodegenerative diseases: therapeutic potential of palmitoylethanolamide in models of Alzheimer's disease.
Scuderi C; Steardo L
CNS Neurol Disord Drug Targets; 2013 Feb; 12(1):62-9. PubMed ID: 23394526
[TBL] [Abstract][Full Text] [Related]
3. Palmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptide.
Scuderi C; Esposito G; Blasio A; Valenza M; Arietti P; Steardo L; Carnuccio R; De Filippis D; Petrosino S; Iuvone T; Di Marzo V; Steardo L
J Cell Mol Med; 2011 Dec; 15(12):2664-74. PubMed ID: 21255263
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer's disease models: the control of neuroinflammation.
Paterniti I; Cordaro M; Campolo M; Siracusa R; Cornelius C; Navarra M; Cuzzocrea S; Esposito E
CNS Neurol Disord Drug Targets; 2014; 13(9):1530-41. PubMed ID: 25106636
[TBL] [Abstract][Full Text] [Related]
5. Palmitoylethanolamide protects dentate gyrus granule cells via peroxisome proliferator-activated receptor-α.
Koch M; Kreutz S; Böttger C; Benz A; Maronde E; Ghadban C; Korf HW; Dehghani F
Neurotox Res; 2011 Feb; 19(2):330-40. PubMed ID: 20221904
[TBL] [Abstract][Full Text] [Related]
6. Palmitoylethanolamide Regulates Production of Pro-Angiogenic Mediators in a Model of β Amyloid-Induced Astrogliosis In Vitro.
Cipriano M; Esposito G; Negro L; Capoccia E; Sarnelli G; Scuderi C; De Filippis D; Steardo L; Iuvone T
CNS Neurol Disord Drug Targets; 2015; 14(7):828-37. PubMed ID: 25801844
[TBL] [Abstract][Full Text] [Related]
7. Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation.
Esposito G; Capoccia E; Turco F; Palumbo I; Lu J; Steardo A; Cuomo R; Sarnelli G; Steardo L
Gut; 2014 Aug; 63(8):1300-12. PubMed ID: 24082036
[TBL] [Abstract][Full Text] [Related]
8. Palmitoylethanolamide Blunts Amyloid-β42-Induced Astrocyte Activation and Improves Neuronal Survival in Primary Mouse Cortical Astrocyte-Neuron Co-Cultures.
Beggiato S; Borelli AC; Ferraro L; Tanganelli S; Antonelli T; Tomasini MC
J Alzheimers Dis; 2018; 61(1):389-399. PubMed ID: 29154284
[TBL] [Abstract][Full Text] [Related]
9. Astrocytic palmitoylethanolamide pre-exposure exerts neuroprotective effects in astrocyte-neuron co-cultures from a triple transgenic mouse model of Alzheimer's disease.
Beggiato S; Cassano T; Ferraro L; Tomasini MC
Life Sci; 2020 Sep; 257():118037. PubMed ID: 32622942
[TBL] [Abstract][Full Text] [Related]
10.
Li M; Wang D; Bi W; Jiang ZE; Piao R; Yu H
J Pharmacol Exp Ther; 2019 Apr; 369(1):163-172. PubMed ID: 30635472
[No Abstract] [Full Text] [Related]
11. Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson's disease.
Esposito E; Impellizzeri D; Mazzon E; Paterniti I; Cuzzocrea S
PLoS One; 2012; 7(8):e41880. PubMed ID: 22912680
[TBL] [Abstract][Full Text] [Related]
12. Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer's disease.
Scuderi C; Stecca C; Valenza M; Ratano P; Bronzuoli MR; Bartoli S; Steardo L; Pompili E; Fumagalli L; Campolongo P; Steardo L
Cell Death Dis; 2014 Sep; 5(9):e1419. PubMed ID: 25210802
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective properties of peroxisome proliferator-activated receptor alpha (PPARα) and its lipid ligands.
Fidaleo M; Fanelli F; Ceru MP; Moreno S
Curr Med Chem; 2014; 21(24):2803-21. PubMed ID: 24606520
[TBL] [Abstract][Full Text] [Related]
14. Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors.
Melis M; Pillolla G; Luchicchi A; Muntoni AL; Yasar S; Goldberg SR; Pistis M
J Neurosci; 2008 Dec; 28(51):13985-94. PubMed ID: 19091987
[TBL] [Abstract][Full Text] [Related]
15. Activation and desensitization of TRPV1 channels in sensory neurons by the PPARα agonist palmitoylethanolamide.
Ambrosino P; Soldovieri MV; Russo C; Taglialatela M
Br J Pharmacol; 2013 Mar; 168(6):1430-44. PubMed ID: 23083124
[TBL] [Abstract][Full Text] [Related]
16. Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator.
Skaper SD; Facci L; Giusti P
Mol Neurobiol; 2013 Oct; 48(2):340-52. PubMed ID: 23813098
[TBL] [Abstract][Full Text] [Related]
17. Differential Effects of Palmitoylethanolamide against Amyloid-β Induced Toxicity in Cortical Neuronal and Astrocytic Primary Cultures from Wild-Type and 3xTg-AD Mice.
Tomasini MC; Borelli AC; Beggiato S; Ferraro L; Cassano T; Tanganelli S; Antonelli T
J Alzheimers Dis; 2015; 46(2):407-21. PubMed ID: 25765918
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 Tat-induced diarrhea is improved by the PPARalpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia.
Sarnelli G; Seguella L; Pesce M; Lu J; Gigli S; Bruzzese E; Lattanzi R; D'Alessandro A; Cuomo R; Steardo L; Esposito G
J Neuroinflammation; 2018 Mar; 15(1):94. PubMed ID: 29573741
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor α mediates acute effects of palmitoylethanolamide on sensory neurons.
Khasabova IA; Xiong Y; Coicou LG; Piomelli D; Seybold V
J Neurosci; 2012 Sep; 32(37):12735-43. PubMed ID: 22972997
[TBL] [Abstract][Full Text] [Related]
20. PPARα-Dependent Effects of Palmitoylethanolamide Against Retinal Neovascularization and Fibrosis.
Ye S; Chen Q; Jiang N; Liang X; Li J; Zong R; Huang C; Qiu Y; Ma JX; Liu Z
Invest Ophthalmol Vis Sci; 2020 Apr; 61(4):15. PubMed ID: 32298438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
